文献速递贫血与红细胞疾病

冷凝集素病的疾病负担:贫血、用药、输血及医疗资源使用的纵向分析

Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization.
PubMed 文献 · Blood Adv · 2017-05-19

该研究利用斯坦福转化研究集成数据库环境,回顾性识别2000年至2016年在斯坦福健康医疗中心诊治的29例冷凝集素病(CAD)患者,分析其贫血严重程度、用药与输血情况以及医疗资源使用。随访期间每患者年观察到7.1次严重贫血事件,每例患者平均接受3.5种治疗,至少65%的队列接受输血,平均每患者年11次输血;发病后第一年93%使用门诊服务,中位每例患者26次门诊就诊。作者指出该单中心经验未涵盖其他医疗机构的诊疗,数据可能代表该时间段内这些患者事件数的最低值。

要点

  • 随访期间每患者年观察到7.1次严重贫血事件。
  • 每例患者平均接受3.5种治疗,至少65%的队列接受输血,平均每患者年11次输血。
  • 发病后第一年93%使用门诊服务,中位每例患者26次门诊就诊。

核心结论

  • 该CAD纵向研究显示贫血严重且疾病具有复发性,即使已给予多种治疗和输血后仍如此。

研究设计与样本

  • 利用斯坦福转化研究集成数据库环境,回顾性识别2000年至2016年在斯坦福健康医疗中心诊断和治疗的CAD患者,共纳入29例。

主要发现

  • 随访期间每患者年观察到7.1次严重贫血事件。
  • 在斯坦福治疗的CAD患者中,每例患者平均接受3.5种治疗。
  • 至少65%的队列接受输血,平均每患者年11次输血。
  • 发病后第一年CAD相关医疗使用中,93%使用门诊服务,中位每例患者26次门诊就诊。

局限性

  • 该单中心经验未涵盖其他医疗机构的诊疗,所呈现的数据可能代表该时间段内这些患者事件数的最低值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cold agglutinin disease (CAD), a rare disease and subtype of autoimmune hemolytic anemia, is characterized by autoantibodies that bind to red blood cells at low temperatures. There is no established standard of care for CAD treatment and CAD cohort studies are limited by the rarity of the condition. The objectives of this study are to present the longitudinal experience of a CAD cohort from the United States, with a focus on anemia severity, use of medications and transfusions, and health care resource utilization. The Stanford Translational Research Integrated Database Environment database was used to retrospectively identify CAD patients diagnosed and treated at Stanford Health Care from 2000 to 2016. Twenty-nine patients were included in this analysis. There were 7.1 severe anemia events per patient-year observed over the follow-up time. For CAD patients treated at Stanford, there was a mean of 3.5 therapies per patient. Transfusions were given in at least 65% of the cohort with a mean of 11 transfusions per patient-year. For CAD-related health care use in the first year after disease onset, 93% used outpatient services with a median of 26 outpatient visits per patient. The data presented here likely represent the minimum number of events for these patients during this timeframe, as this single-center experience does not capture care from other providers. This longitudinal study of CAD patients demonstrates the severity of anemia and relapsing nature of the disease, even after administration of multiple therapies and transfusions.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Mullins M, Jiang X, Bylsma LC, et al. Cold agglutinin disease burden: a longitudinal analysis of anemia, medications, transfusions, and health care utilization. Blood Adv. 2017. PMID: 29296728. doi:10.1182/bloodadvances.2017004390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。